Yilmaz, Musa
Daver, Naval
Article History
First Online: 20 June 2019
Compliance with Ethical Standards
:
: No external funding was used in the preparation of this article.
: Naval Daver has received research funding from: Pfizer, BMS, Novartis, Daiichi-Sankyo, Karyopharm, Incyte, Abbvie, Servier, Genentech, Nohla, Glymomimeticsm Immunogen; Advisory/Consulting: Prizer, Novartis, BMS, Otsuka, Celgene, Incyte, Jazz, Karyopharm, Sunesis, Immunogen, Abbvie, Astellas, Daiichi-Sankyo, Agio; Honoraria: BMS, Jazz, Novartis, Incyte, Otsuka, Immunogen, Pfizer, Astellas, Abbvie. Musa Yilmaz declares no conflicts of interest that might be relevant to the contents of this article.